Thymosin beta-4 and TB-500: the actin-binding repair pathway
Thymosin beta-4 is a 43-amino-acid protein found in nearly every cell. TB-500 corresponds to its actin-binding fragment, and most of the evidence is still preclinical.
Thymosin beta-4 is a 43-amino-acid protein found in nearly every cell, and it sits at the center of one of the most closely studied repair pathways in current peptide research. TB-500 is the synthetic research peptide corresponding to its active actin-binding fragment.
From thymic tissue to platelets and wound fluid
Thymosin beta-4 was first isolated from thymic tissue, which gave it its name. It was later found expressed throughout the body, with notable concentrations in platelets and wound fluid.
Mechanism: G-actin sequestration
Its core mechanism is G-actin sequestration. Thymosin beta-4 binds monomeric actin, which supports rapid polymerization of the actin cytoskeleton during cell migration.
Downstream, the literature points to three recurring effects:
- Angiogenesis
- Reduced inflammatory signaling
- Accelerated keratinocyte and endothelial cell migration
These effects have been reported across skeletal muscle, tendon, cardiac, neurological and ocular models.
The gap in the evidence
Most of this evidence is preclinical, from animal and cell culture work. Human clinical data remains limited.
The regulatory picture is also unsettled. As of August 2026, the FDA's 503A Bulk Drug Substances List review for this compound category was active and unresolved.